Clinical Exploration on the Reversal of Diastolic Dysfunction

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONRC-11001636

Enrollment

Unknown

Registered

2011-09-29

Start date

2010-04-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diastolic Dysfunction

Interventions

A:Creatine Phosphate Sodium for Injection

B:Danshen injection

Eligibility

Sex/Gender

All

Age

20 Years to 84 Years

Inclusion criteria

Inclusion criteria: Participants with diseases of Hypertension, Hypertensive Heart Disease, Coronary Artery Disease, Diabetes, Arteriosclerosis, Valvular Heart Disease was screened according to: 1) the Diagnostic Flow Chart of Diastolic Heart Failure formulated by the European society of cardiology in 2007; 2) The New Concept of Diastolic heart failure' written by Jihong Guo; 3) the Consolidated Guideline on the assessment of Diastolic Function of Left Ventriclethe formulated by the United States and European society of Echocardiography.

Exclusion criteria

Exclusion criteria: Left ventricular ejection fraction <50%

Design outcomes

Primary

Measure	Time frame
Histology and blood flow Doppler imaging presentation;	—

Countries

China

Contacts

Public ContactYing Wang

wy19581105@sina.com+86 13998503666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026